# AnSheng Medical Equipment (Nanjing) Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ansheng-medical-equipment-nanjing-co

- Industry: Medical Devices & Equipment
- Headquarters: Nanjing, China
- Website: www.minimaxmed.com
- Total disclosed funding: $15M
- Latest round: Series B (Dec 30, 2022)
- Investors on record: 4

## About

Established in 2014 and based in Nanjing, China, AnSheng Medical Equipment (Nanjing) Co., Ltd. operates as an intelligent precision minimally invasive diagnosis and treatment platform developer that provides minimally invasive surgical instruments in the field of minimally invasive tumor, minimally invasive vascular, minimally invasive hemorrhoids and surgical treatment. The company is headquartered in Nanjing and has branches located in Shanghai, Guangzhou and Hongkong. Products obtained EU CE certification and have been installed in more than 400 tertiary hospitals. In January 2023, Ansheng Medical raised approximately CNY 100 million in series B funding led by Ming Bioventures.

The company provides intelligent precision minimally invasive diagnosis and treatment platform. Its product are divided into self-developed products and agent products. Self-developed products include biohara minimally invasive radiofrequency ablation system, biogen minimally invasive hemorrhoid radiofrequency ablation system, biogen minimally invasive interventional surgery robot, electromagnetic spectrum products and ultrasound products. Agent products include FCARE EVRF, angiodynamics RITA and angiodynamics habib 4X.

## Funding rounds

- Series B, Dec 30, 2022, $15M — Cowin Capital, Addor Capital, Ming Bioventures
- Series A, Nov 14, 2017 — Addor Capital, Yunyeyuan Capital

## Investors

- Addor Capital (https://capitalatlas.ai/funds/addor-capital) — Series A, Series B
- Yunyeyuan Capital — Series A
- Cowin Capital (https://capitalatlas.ai/funds/cowin-capital) — Series B
- Ming Bioventures (https://capitalatlas.ai/funds/ming-bioventures) — Series B